Literature DB >> 18187077

Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain.

Shaun Wen Huey Lee1, Men Long Liong, Kah Hay Yuen, Wing Seng Leong, Christopher Chee, Phaik Yeong Cheah, Weng Pho Choong, Yue Wu, Nurzalina Khan, Wooi Long Choong, Hin Wai Yap, John N Krieger.   

Abstract

BACKGROUND: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) afflicts 2%-10% of adult men. Available therapies offer little or no proven benefit. Because acupuncture represents an attractive "natural" therapy, we compared the efficacy of acupuncture to sham acupuncture for CP/CPPS.
METHODS: Participants met US National Institutes of Health (NIH) consensus criteria for CP/CPPS, were aged > or = 20 years old, and had a total score > or = 15 on the NIH Chronic Prostatitis Symptom Index (NIH-CPSI) and symptoms for at least 3 of the preceding 6 months. They were randomized 1:1 to acupuncture or sham acupuncture. Treatment consisted of twice-weekly 30-minute sessions for 10 weeks (20 sessions total) without needle stimulation, herbs, or adjuvants. The primary response criterion was a 6-point decrease from baseline to week 10 in NIH-CPSI total score (range 0-43).
RESULTS: Thirty-two (73%) of 44 participants responded in the acupuncture group compared with 21 (47%) of 45 sham group participants (relative risk 1.81, 95% confidence interval, 1.3-3.1, P = .02). Long-term responses 24 weeks after completing therapy without additional treatment occurred in 14 (32%) of 44 acupuncture group participants and in 6 (13%) of 45 sham group participants (relative risk 2.39, 95% confidence interval, 1.0-5.6, P = .04).
CONCLUSIONS: After 10 weeks of treatment, acupuncture proved almost twice as likely as sham treatment to improve CP/CPPS symptoms. Participants receiving acupuncture were 2.4-fold more likely to experience long-term benefit than were participants receiving sham acupuncture.

Entities:  

Mesh:

Year:  2008        PMID: 18187077      PMCID: PMC4497585          DOI: 10.1016/j.amjmed.2007.07.033

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  Standards for reporting interventions in controlled trials of acupuncture: The STRICTA recommendations. STandards for Reporting Interventions in Controlled Trails of Acupuncture.

Authors:  Hugh MacPherson; Adrian White; Mike Cummings; Kim Jobst; Ken Rose; Richard Niemtzow
Journal:  Acupunct Med       Date:  2002-03       Impact factor: 2.267

Review 2.  Epidemiology of prostatitis: new evidence for a world-wide problem.

Authors:  John N Krieger; Donald E Riley; Phaik Yeong Cheah; Men Long Liong; Kah Hay Yuen
Journal:  World J Urol       Date:  2003-04-24       Impact factor: 4.226

Review 3.  Interventions for chronic abacterial prostatitis.

Authors:  C McNaughton; R Mac Donald; T Wilt
Journal:  Cochrane Database Syst Rev       Date:  2001

4.  Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men.

Authors:  Rodney U Anderson; David Wise; Timothy Sawyer; Christine Chan
Journal:  J Urol       Date:  2005-07       Impact factor: 7.450

5.  Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.

Authors:  Richard B Alexander; Kathleen J Propert; Anthony J Schaeffer; J Richard Landis; J Curtis Nickel; Michael P O'Leary; Michel A Pontari; Mary McNaughton-Collins; Daniel A Shoskes; Craig V Comiter; Nand S Datta; Jackson E Fowler; Robert B Nadler; Scott I Zeitlin; Jill S Knauss; Yanlin Wang; John W Kusek; Leroy M Nyberg; Mark S Litwin
Journal:  Ann Intern Med       Date:  2004-10-19       Impact factor: 25.391

6.  Demographic and clinical characteristics of chronic prostatitis: prospective comparison of the University of Sciences Malaysia Cohort with the United States National Institutes of Health Cohort.

Authors:  Shaun Wen Huey Lee; Phaik Yeong Cheah; Men Long Liong; Kah Hay Yuen; Anthony J Schaeffer; Kathleen Propert; John N Krieger
Journal:  J Urol       Date:  2007-01       Impact factor: 7.450

Review 7.  Core outcome domains for chronic pain clinical trials: IMMPACT recommendations.

Authors:  Dennis C Turk; Robert H Dworkin; Robert R Allen; Nicholas Bellamy; Nancy Brandenburg; Daniel B Carr; Charles Cleeland; Raymond Dionne; John T Farrar; Bradley S Galer; David J Hewitt; Alejandro R Jadad; Nathaniel P Katz; Lynn D Kramer; Donald C Manning; Cynthia G McCormick; Michael P McDermott; Patrick McGrath; Steve Quessy; Bob A Rappaport; James P Robinson; Mike A Royal; Lee Simon; Joseph W Stauffer; Wendy Stein; Jane Tollett; James Witter
Journal:  Pain       Date:  2003-12       Impact factor: 6.961

8.  Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.

Authors:  Phaik Yeong Cheah; Men Long Liong; Kah Hay Yuen; Chu Leong Teh; Timothy Khor; Jin Rong Yang; Hin Wai Yap; John N Krieger
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

9.  Reliability and validity of the National Institutes of Health: Chronic Prostatitis Symptom Index in a Malaysian population.

Authors:  Phaik Yeong Cheah; Men Long Liong; Kah Hay Yuen; Shaun Lee; Jin Rong Yang; Chu Leong Teh; Timothy Khor; Hin Wai Yap; John N Krieger
Journal:  World J Urol       Date:  2006-02-08       Impact factor: 4.226

10.  Acupuncture ameliorates symptoms in men with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Richard Chen; J Curtis Nickel
Journal:  Urology       Date:  2003-06       Impact factor: 2.649

View more
  45 in total

1.  Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham-controlled trial.

Authors:  S Sahin; M Bicer; G A Eren; S Tas; V Tugcu; A I Tasci; M Cek
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-05-05       Impact factor: 5.554

2.  Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study.

Authors:  Shaun Wen Huey Lee; Men Long Liong; Kah Hay Yuen; John N Krieger
Journal:  Complement Ther Med       Date:  2014-10-23       Impact factor: 2.446

Review 3.  Efficacy of acupuncture in the treatment of chronic prostatitis-chronic pelvic pain syndrome: a review of the literature.

Authors:  Junaid Wazir; Rahat Ullah; Shihong Li; Md Amir Hossain; Maladho Tanta Diallo; Farhan Ullah Khan; Awais Ullah Ihsan; Xiaohui Zhou
Journal:  Int Urol Nephrol       Date:  2019-08-29       Impact factor: 2.370

Review 4.  Minimally invasive therapies for chronic pelvic pain syndrome.

Authors:  Salim A Wehbe; Jennifer Y Fariello; Kristene Whitmore
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

5.  Advancements in the management of urologic chronic pelvic pain: what is new and what do we know?

Authors:  Justin Parker; Sorin Buga; Jose E Sarria; Philippe E Spiess
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

Review 6.  Alternative therapies for the treatment of chronic prostatitis.

Authors:  Lara K Suh; Franklin C Lowe
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

7.  Issues of design and statistical analysis in controlled clinical acupuncture trials: an analysis of English-language reports from Western journals.

Authors:  Ping Shuai; Xiao-Hua Zhou; Lixing Lao; Xiaosong Li
Journal:  Stat Med       Date:  2011-02-22       Impact factor: 2.373

8.  Brain Functional Interaction of Acupuncture Effects in Diarrhea-Dominant Irritable Bowel Syndrome.

Authors:  Kai Ma; Yongkang Liu; Wei Shao; Jianhua Sun; Jing Li; Xiaokun Fang; Jing Li; Zhongqiu Wang; Daoqiang Zhang
Journal:  Front Neurosci       Date:  2020-12-15       Impact factor: 4.677

9.  [Chronic pelvic pain syndrome: neurostimulation, neuromodulation and acupuncture].

Authors:  M Walter; U Sammer; T M Kessler
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

Review 10.  Complementary and alternative treatments for chronic pelvic pain.

Authors:  Adam J Carinci; Ravi Pathak; Mark Young; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.